Quinuclidin-3-one (1) was used as a versatile intermediate for the synthesis of fused and spiro quinuclidine and its C-nucleosides. The reaction of 1 with formalin and secondary amines namely; morpholine, piperidine, and piperazine afforded the corresponding Mannich bases 2-4 in acid medium. Quinuclidino[3,2-b]pyran 5 has been synthesized via a selective cyclocondensation reaction between Mannich base of quinuclidinone hydrochloride 2 and malononitrile. The transformation of 1 with formalin and methylamine in molar ratio (1:20:2) afforded the spiro compound 7. Ring expansion of 2 under Schmidt reaction conditions gave the 1,3-diazabicyclo[3.2.2]nonanone derivative 6. Eventually, the synthesis of C-nucleosides 10, 12-14 were achieved by using aldohexoses and aldopentose catalyzed by zinc chloride, while, the bis-quinuclidine derivative 15 was obtained by using sodium carbonate. Newly synthesized compounds were characterized by IR, 1 H NMR, and mass spectral data.
Introduction
Quinuclidine is a part of the structure of a number of natural physiologically active compounds and synthetic drugs [1] [2] [3] . Some functionalized synthetic quinuclidines have also been identified as specific muscarinic agonists with potential in Alzheimer's dementia therapy [4, 5] . Also, used in the synthesis of higher thermodynamic stability of quinuclidine complexes, as 1-quinuclidine-1-boraadamantane [6] . Moreover a variety of quaternary quinuclidinium salts synthesized via the Menschutkin reaction as N-ethoxycarbonylmethyl-quinuclidinium chloride dihydrate, QNBE-Cl-2H2O and quinuclidine betaine hydrate (N-carboxymethyl-quinuclidinium inner salt, QNB-H2O) [7, 8] . As much as the incorporation of Mannich bases into heterocyclic moieties is known to improve their pharmacological properties [9, 10] , as well as synthetic potentialities [11] [12] [13] [14] [15] , it seemed interesting to prepare the Mannich bases of quinuclidin-3-one (1) to investigate their synthetic potentialities. The Menschutkin reaction results in formation of a variety of quaternary quinuclidinium salts. Recently, the structures of N-ethoxycarbonylmethylquinuclidinium chloride dihydrate, QNBE-Cl-2H2O, [7, 8] and quinuclidine betaine hydrate (N-carboxymethyl-quinuclidinium inner salt, QNB-H2O) [7, 8] were reported.
We reported herein the synthesis of novel heterocycleannulated quinuclidine(1-azabicyclo[2.2.2]octane) and spiro compounds and also ring expansion based on the starting quinuclidine which also reacted with different aldohexose and aldopentose derivatives.
Experimental

Instrumentation
All melting points were determined on Gallenkamp electric melting point apparatus. Elemental analyses were performed on an ECS 4010 Elemental combustion system at the Microanalytical Unit, Faculty of Science, Cairo University. The FTIR spectra were measured using KBr disc on a Mattson 5000 FTIR spectrometer. The 1 H NMR data were obtained in CDCl3 or DMSO-d6 on Varian XL 200 MHz instrument using TMS as internal standard. Chemical shifts were reported in ppm (δ) downfield from internal TMS and coupling constants were expressed in hertz. Electron impact (EI) Mass spectra were recorded on GC-MS QP-1000 EX. Shimadzu Instrument at 70 ev. Reactions were monitored by thin layer chromatography (TLC) using EM science silica gel coated plates with visualization by irradiation with ultraviolet lamp. The starting quinuclidine (1) of code number (Q190-5) was purchased from Aldrich Company.
Synthesis
4-((3-Oxoquinuclidin-2-yl)methyl)morpholin-4-ium chloride (2) and 1-((3-oxoquinuclidin-2-yl)methyl) piperidinium acetate (3)
General procedure: A mixture of 1 (0.8 g, 5 mmol), formalin (6 mmol) and morpholine or piperidine (5 mmol) was refluxed in ethanol (15 cm 3 ) for 8 h over water bath. After adding few drops of hydrochloric or acetic acids, the precipitate was formed, filtered off, dried and crystallized from ethanol to afford salts of Mannich bases 2 and 3, respectively (Scheme 1). 
4-((3-Oxoquinuclidin-2-yl)methyl)morpholin-4-ium chloride
2-Morpholin-4-ylmethyl-1,3-diaza-bicyclo[3.2,2] nonan-4-one (6)
To a stirred mixture of sulphuric acid (10 cm 3 , 90%) and chloroform (20 cm 3 ) at 0°C, was added a solution of 2 (1.04 g, 4 mmol) in ethanol (5 cm 3 ) followed by addition of sodium azide (0.26 g, 4 mmol). The reaction mixture was stirred at 0°C for 1 h, then further at 25°C for 4 h. It was diluted with ice water basified with ammonia (40%), then extracted with ether (3 x 15 cm 3 ); the ether solution was dried on sodium sulphate and evaporated under vacuum to give a solid product which was crystallized from ether/petroleum ether 40-60°C to give 6 as white crystals (Scheme 1 
1,4-Ethano-8,10-dimethyl-1,8,10-triaza-spiro[5.5] undecan-5-one (7)
A solution of 1 (0.8 g, 5 mmol) in ethanol (15 cm 3 ) and formalin (7.5 cm 3 , 100 mmol) was heated at 60°C for 2 h, then methylamine (0.45 g, 10 mmol, 33%) and excess formalin (0.5 cm 3 ) were added. The reaction mixture was further heated for 3 h. The formed precipitate after cooling the reaction mixture was filtered off, dried and crystallized from ethanol to afford 7 as white crystals (Scheme 1). Yield: 35%. M.p.: 240 °C. 1 10. 1,2,3,4,5,6,7,8-Octahydro-9-(1,2,3,4,5-pentahydroxy-1-pent-1-yl)-10-oxa-1,8-diaza-1,4 
2-Arabinopyranosyloxy-1-aza-bicyclo[2.2.2]octan-3-one
2.2.
Results and discussion
The target compounds were synthesized as outlined in Schemes 1-6. In light of the aforementioned importance of ketonic Mannich bases as precursors for the synthesis of heterocycle-annulated quinuclidine(1-azabicyclo[2.2.2]octane) derivatives, therefore compound 1 was subjected to Mannich reaction with morpholine, piperidine and formalin in a molar ratio (1:1:1.2) to afford salts of the Mannich bases 2 and 3, respectively, which were reported as free bases [16] . In addition, the interesting pharmacological activity of piperazine derivatives [17] [18] [19] , prompted us to prepare 1,4-bis(4-ylmethyl-1-aza-bicyclo[2.2.2]octane-3-one)piperazine (4) through the reaction of 1 with piperazine and formalin in a molar ratio of (2:1:2) (Scheme 1).
Formulation of structures 2-4 was based on elemental analysis, IR and 1 H NMR spectra. In addition the mass fragmentation pattern of 2 showed a good agreement with its proposed structure. Cleavage of the side chain led to fragment at m/z 138 (11%) characteristic to 2-methylenequinuclidin-3-one. Also cleavage of the side chain at the β-bond led to strong peak at m/z 100 which is due to [CH2N + (CH2CH2)2O] fragment and the base peak at m/z 55. This peak is probably due to fragmentation of the morpholinomethylene (Scheme 4).
Ketonic Mannich bases are of considerable importance as versatile precursors in the synthesis of heterocycles [20] [21] [22] . With a view to effect a "one-pot" C-alkylation and cyclization of the Mannich base 2, the reaction of 4-((3-oxoquinuclidin-2-yl)methyl)morpholin-4-ium chloride (2) with malononitrile in refluxing toluene was implemented to give 2-amino-3-cyanoquinuclidino[3,2-b]pyran(5-amino-6-oxa-1-aza-tricyclo [6.2.2.0 2,7 ]dodeca-2(7),4-diene-carbonitrile) (5). Its structure was supported by elemental and spectral data. Presumable the formation of 5 proceeds via deamination of the Mannich base 2 to form 2-methylenequinuclidine-3-one which undergoes thermal Micheal addition of the acidic methylene group of malononitrile followed by nucleophilic addition of enolic OH group to the carbon atom of cyano group (Scheme 5).
When compound 2 was treated with sodium azide in presence of sulfuric acid under Schmidt condition gave the 1,3-diazepine derivative 6 as bridged diazepine anchored N-morpholinomethyl side chain.
Scheme 5 Scheme 6
This method can be considered as alternate route to obtain 1,3-diazepine derivatives which incorporate N-basic side chain at C-2 of the diazepine nucleus since the direct condensation of 1,3-diazepine with formaldehyde gave the N-bis compound. Formulation of structure 6 was proved in light of its elemental analysis, IR and mass spectral data. Its mass spectrum added further support to the assigned structure, as it revealed the molecular ion peak at m/z 239 (M + , 75%).
The quinuclidine nucleus is the core component of the cinchona alkaloids, a family of natural products, which not only exhibited antimalarial activity but also found to be widespread use in numerous asymmetric transformations [23] [24] [25] [26] [27] , and pyrimidine derivatives from bridged alicyclic ketones act as dihydrofolate reductase inhibitor [28] . Consequently, 1 was transformed with a mixture of formalin and methylamine in molar ratio (1:20:2) under Mannich conditions to afford 1,4-ethano-8,10-dimethyl-1,8,10-triaza-spiro [5.5] undecan-5-one (7) as spiro compound. It was probably formed through the formation of the intermediate 2,2-bis-methylol-3-quinuclidinone followed by amination with methylamine, then by subsequent cyclization with excess of formalin (Scheme 6). This mechanism was supported by the work of Nielsen [29] [via formation of the intermediate 2,2-bis-methylol-3-quinuclidinone. Formulation of structure 7 was proved in light of its elemental analysis, IR, 1 H NMR and mass data. In addition the Mannich base analogue 8 was synthesized by treatment of 1 with glucose and morpholine under Mannich reaction conditions (Scheme 1).
A series of spirohydantoins [30, 31] , were reported as compounds have several pharmacological activities [32, 33] . Therefore, we synthesized spirothiohydantoin 9 for the sake of improving pharmacological potency of quinuclidine. Hence, quinuclidinone 1 was transformed by potassium cyanide and thiourea in ethanol into 9. The reaction pathway was proceeded via cyanohydrin intermediate [34] , followed by condensation with thiourea to furnish compound 9 (Scheme 2). The structure of 9 was proved by its IR, 1 H NMR and mass spectra. The IR spectrum of 9 revealed a broad band in the 2500-2800 cm -1 region, similar to the absorption formed in other azabicyclospirohydantoins [35] , this absorption is explained by the existence of an intermolecular hydrogen bond which is formed between the weak acid N-3`H group and the basic 1-aza-bicylco[2.2.2]octane nitrogen atom. The N-1`H stretching vibration originates a band in the 3311 cm -1 region.
The carbonyl region shows a very strong band at 1736 cm -1 ; and also strong band at 1087 cm -1 characteristic for C=S. This interpretation is supported by studies carried out on other azabicyclo-spirohydantoins [36] .
The discovery of C-nucleosides and their antibacterial and antitumor properties [37] [38] [39] [40] , and also electrophilic Cglycosylation of electron rich aromatic and the heterocyclic systems is widely found in nature [37] [38] [39] [40] . Therefore, our attention was directed to the development of synthetic routes to this class of compounds. Surprisingly, a facile synthesis of Cnucleoside derivatives of quinuclidin-3-one (1) was achieved by the reaction with different aldoses. In this method, the reaction of 1 with D-glucose was conducted in absolute ethanol at 60 o C for 20 min. in the presence of catalytic amount of zinc chloride to give the cyclic C-nucleoside analogue 10. In a similar way, the reaction of the hexoses, e.g., D-galactose and Dmannose, and the pentoses, L-arabinose with 1 gave 2-(aldilol-1-yl)quinuclidin-3-ones 12-14 (Scheme 3).
The acetylation of 10 was implemented using acetic anhydride and acetic acid mixture with subsequent dehydration to give the acetylated C-nucleoside 11. The mass spectrum of 11 showed the molecular ion peak at m/z 454 (M + -H, 0.51%).
Formulation of structure 10 was based on elemental analysis, IR, UV, 1 H NMR and mass spectral data. The coupling constant of the anomeric proton was 3.4 Hz indicated the α-configuration of the glucose moiety. Its mass spectrum showed the molecular ion peak at m/z 287 (M + , 6.5%).
On the other hand, condensation of 1 with D-glucose in sodium carbonate as a basic catalyst instead of zinc chloride afforded the bis-quinuclidine sugar 15. Its structure was confirmed by elemental analysis and mass spectrum. Its mass spectrum showed the molecular ion peak at m/z 394 (M + , 60%).
